The global Novel Drug Delivery Systems in Cancer Therapy market size is expected to be worth around US$ 36.61 billion by 2030, according to a new report by Vision Research Reports.
The global Novel Drug Delivery Systems in Cancer Therapy market size was valued at US$ 14.31 billion in 2020 and is anticipated to grow at a CAGR of 30.9% during forecast period 2021 to 2030.
The market is primarily driven by global rise in incidence of cancer, increase in research activities for developing novel drug delivery technologies, and availability of research funding for ongoing projects.
Many key players in this market are investing in R&D of novel and advanced products. This can also be attributed to increase in patent expirations. For instance, the R&D expenditure of Celgene Corporation increased from USD 3,697.3 million in 2015 to USD 4,470.1 million in 2016. Increase in R&D spending was directed toward enhancing product pipeline and for regulatory approvals of new products.
In addition, rise in healthcare expenditure for diagnosis and treatment of cancer and awareness about alternative therapies are expected to boost market growth. Improvement in healthcare infrastructure in developing nations and increase in awareness about new treatment methods for cancer are also anticipated to propel the market during the forecast period.
North America held the largest market share in 2016. Local presence of a large number of manufacturers, ongoing regulatory approvals for new drugs, and availability of research funding for new methods of treatment for this disorder are key factors that can be attributed to this region’s dominance in the global market. However, Asia Pacific is expected to grow at the highest rate during the forecast period. This can be attributed to rise in initiatives that boost cancer research projects, increase in healthcare expenditure for cancer therapy, improvement in healthcare infrastructure, large geriatric population base, and rise in awareness owing to medical conferences and meetings in the region.
Based on the type of novel drug delivery systems, the market is segmented into nanoparticles and embolization particles. Nanoparticles are further segmented into liposomes, polymers, micelles, and other nanoparticles. In 2016, the nanoparticles segment held the largest market share by product and is expected to continue its dominance over the novel drug delivery systems in cancer therapy market throughout the forecast period.
Nanoparticles as novel drug delivery systems are a unique approach in cancer treatment. They encapsulate the drugs and protect them against chemical and enzymatic degradation. Nanoparticles in drug delivery provide long circulation half-lives, help in reducing side effects, and improve pharmacokinetics. These particles also offer enhanced permeability, which allows the efficient delivery of drugs to cancer tissues. Nanoparticles as novel drug delivery systems are thus considered a promising approach to replace traditional chemotherapy, a treatment that poses a serious risk to healthy tissues.
Nanoparticle delivery systems such as liposomes and micelles are often used to increase drug efficacy and DNA delivery and targeting. Continuous improvements in the therapeutic properties of drugs have increased the demand for novel drug delivery systems. In 2016, liposomes held the largest share in the nanoparticles segment, by type. This sub-segment is also expected to grow at the highest rate during the forecast period.
Tumor embolization is a process of blocking blood vessels that supply oxygen and blood to tumors. The embolization particles segment is further categorized into PVA particles, drug-eluting beads, liquid emboli, and other embolization particles. These particles are injected into small vessels supplying blood to cancer cells. This procedure allows for easy surgical resection of cancer cells, resulting from reduced blood loss.
North America dominated the market in 2016 with a revenue share of around 36.8%. Key factors contributing to the growth of this market include rise in the number of research activities for new therapies, increase in budget for novel drug discovery, growing awareness due to marketing and promotional activities of manufacturers, and increasing incidence of cancer. In addition, FDA approvals for commercial availability of NDDS and rise in number of clinical trials for this therapy are expected to boost market growth in this region.
The Asia Pacific market for novel drug delivery systems in cancer therapy is anticipated to grow at the fastest rate during the forecast period. This can be attributed to rising incidence of cancer in China and Japan, increase in geriatric population in Japan, collaborations between U.S. and China to strengthen cancer research, and rise in awareness about new therapies in Asia Pacific. In addition, increase in research activities in Asia Pacific countries is expected to boost market growth during the forecast period.
Europe held the second-largest share in this market in 2016. The European market is expected to grow significantly owing to presence of a large number of cancer patients, rise in research funding for cancer therapies, increase in awareness about novel therapies among cancer patients, and high healthcare expenditure in the region.
Ltd.; Johnson & Johnson Services, Inc.; GALEN; Merrimack Pharmaceuticals, Inc.; Shire; Samyang Biopharmaceuticals Corporation; Celgene Corporation; Spectrum Pharmaceuticals, Inc.; and BTG.
Other embolization particles
The Novel Drug Delivery Systems in Cancer Therapy market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Novel Drug Delivery Systems in Cancer Therapy market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Novel Drug Delivery Systems in Cancer Therapy market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems in Cancer Therapy market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Novel Drug Delivery Systems in Cancer Therapy market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Novel Drug Delivery Systems in Cancer Therapy capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Novel Drug Delivery Systems in Cancer Therapy by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Novel Drug Delivery Systems in Cancer Therapy market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Novel Drug Delivery Systems in Cancer Therapy market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Novel Drug Delivery Systems in Cancer Therapy market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Novel Drug Delivery Systems in Cancer Therapy industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Novel Drug Delivery Systems in Cancer Therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Novel Drug Delivery Systems in Cancer Therapy market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Novel Drug Delivery Systems in Cancer Therapy market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Novel Drug Delivery Systems in Cancer Therapy market. These factors have benefited the growth of the global market for Novel Drug Delivery Systems in Cancer Therapy. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Novel Drug Delivery Systems in Cancer Therapy. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Novel Drug Delivery Systems in Cancer Therapy are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are: